Japan Apheresis Registry

Japan Apheresis Registry - JAR

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039498

Enrollment

10000

Registered

2020-04-01

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Any Conditions Requiring Therapeutic Apheresis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All the patients who received apheresis therapy at the facility which participates in this registry during the study period and who or whose care-givers do not express their intention to opt-out from this registry.

Exclusion criteria

Exclusion criteria: The patients who or whose care givers expressed their intention to opt-out from this registry, or the patients who were judged ineligible for the study by the doctors in charge

Design outcomes

Primary

Measure	Time frame
Distribution of indications and therapeutic conditions of apheresis therapies	—

Secondary

Measure	Time frame
1. Association between primary outcomes and patient characteristics. 2. Adverse events and their details 3. Patient survival for one year	—

Countries

Japan

Contacts

Public ContactTakafumi Ito

Japanese Society for Apheresis Working Group for Japan Apheresis Registry

apheresis@shunkosha.com03-5291-6231

Outcome results